Insider Trading: Acorda Therapeutics Inc (ACOR.O)

ACOR.O on Nasdaq

31.43USD
11 Jul 2014
Price Change (% chg)

$0.12 (+0.38%)
Prev Close
$31.31
Open
$31.21
Day's High
$31.57
Day's Low
$30.93
Volume
258,881
Avg. Vol
631,413
52-wk High
$39.94
52-wk Low
$27.51

Search Stocks
WASMAN JANE Options Exercised: 0
Trade Date: Sunday, 2 Dec 2012 Price: 24.20
Title: General Counsel Shares Held: 97,951
Type Traded: Direct Net Change in Shares This Filing: -7,019

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 213
Total Shares Held: 42,897,598
3 Mo. Net Change: 276,509
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 4
# Reduced Positions: 4
# Net Buyers: 0

Officers & Directors

Name Age Since Current Position

Ron Cohen

58 President,Chief Executive Officer, Director

Michael Rogers

54 2013 Chief Financial Officer

Lauren Sabella

53 2010 Executive Vice President - Commercial Development

Andrew Blight

63 2004 Chief Scientific Officer

Jane Wasman

57 2012 President - International, General Counsel, Corporate Secretary

Enrique Carrazana

52 2011 Chief Medical Officer

Andrew Asa Hindman

2014 Chief Business Development Officer

David Lawrence

56 2013 Chief - Business Operations

Barry Greene

50 2007 Independent Director

Peder Jensen

59 2011 Independent Director

John Kelley

60 2008 Independent Director

Sandra Panem

67 1998 Independent Director

Lorin Randall

70 2006 Independent Director

Steven Rauscher

60 2005 Independent Director

Ian Smith

48 2007 Independent Director
Search Stocks